D
Exagen Inc. XGN
$4.60 -$0.29-5.93% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2025 06/30/2025 03/31/2025 12/31/2024 09/30/2024
Net Income -12.48% 1.93% 19.91% 36.19% 47.87%
Total Depreciation and Amortization 6.44% -12.81% -17.70% -20.48% -16.74%
Total Amortization of Deferred Charges 93.96% 27.92% 5.30% -1.28% -7.45%
Total Other Non-Cash Items 43.79% -26.68% -52.16% -53.88% -54.76%
Change in Net Operating Assets -107.08% -224.30% -56.65% -1,046.46% 153.77%
Cash from Operations -93.63% -155.09% -8.41% 8.18% 81.46%
Capital Expenditure -56.42% -86.36% -4.63% 37.80% 57.89%
Sale of Property, Plant, and Equipment -72.73% -72.73% -75.00% -- 1,000.00%
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -62.69% -97.73% -8.50% 35.95% 59.77%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -2,288.55% -2,220.90% 91.57% 92.13% 92.09%
Issuance of Common Stock 11,243.94% 8,155.41% 26.41% -35.29% -46.05%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 3,788.61% 3,392.35% 94.12% 93.76% 93.70%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 312.33% 179.49% 35.49% 44.18% 84.07%